VXRT – Vaxart, Inc.

Vaxart, Inc. - Common Stock

VXRT

$0.3439

Name : Vaxart, Inc. - Common Stock

Sector : Healthcare

Industry: Biotechnology

Mark. Cap: $78,480,728.00

EPSttm : -0.33

Vaxart, Inc. - Common Stock

$0.3439

1.43%

$0.005

Float Short %

5.8

Margin Of Safety %

Put/Call OI Ratio

0.07

EPS Next Q Diff

-0.03

EPS Last/This Y

EPS This/Next Y

-0.05

Price

0.34

Target Price

4.67

Analyst Recom

Performance Q

-53.62

Relative Volume

0.45

Beta

1.33

Ticker: VXRT

22 items of 1

Date	Symbol	Last	P/C OI	P/C Vol	Total OI
2025-03-20	VXRT	0.5648	0.15	0.07	12275
2025-03-21	VXRT	0.51	0.15	0.08	12409
2025-03-24	VXRT	0.5109	0.14	0.02	10925
2025-03-25	VXRT	0.483	0.14	1.96	11243
2025-03-26	VXRT	0.4671	0.15	1.09	11582
2025-03-27	VXRT	0.4608	0.15	0.03	11600
2025-03-28	VXRT	0.421	0.15	0.33	11611
2025-03-31	VXRT	0.4199	0.13	0.08	11482
2025-04-01	VXRT	0.3721	0.10	0.36	11377
2025-04-02	VXRT	0.3551	0.10	0.01	11389
2025-04-03	VXRT	0.382	0.10	0.00	11400
2025-04-04	VXRT	0.3361	0.10	0.00	11915
2025-04-07	VXRT	0.3111	0.10	0.01	12030
2025-04-08	VXRT	0.3059	0.09	0.02	12252
2025-04-09	VXRT	0.3308	0.09	0.03	12317
2025-04-10	VXRT	0.3172	0.09	0.08	12750
2025-04-11	VXRT	0.3544	0.09	0.00	12916
2025-04-14	VXRT	0.3515	0.09	0.05	13009
2025-04-15	VXRT	0.3554	0.08	0.00	12909
2025-04-16	VXRT	0.3489	0.07	0.00	13001
2025-04-17	VXRT	0.3409	0.07	0.01	12956
2025-04-18	VXRT	0.3439	0.07	0.01	12956
Date	Symbol	Last	P/C OI	P/C Vol	Total OI

22 items 1 of 1

22 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-03-20	VXRT	0.57	8.3	-	-0.40
2025-03-21	VXRT	0.51	8.3	-	-0.40
2025-03-24	VXRT	0.51	35.7	-	-0.40
2025-03-25	VXRT	0.48	35.7	-	-0.40
2025-03-26	VXRT	0.46	35.7	-	-0.40
2025-03-27	VXRT	0.45	35.7	-	-0.40
2025-03-28	VXRT	0.42	35.7	-	-0.34
2025-03-31	VXRT	0.41	50.0	-	-0.34
2025-04-01	VXRT	0.37	50.0	-	-0.34
2025-04-02	VXRT	0.35	50.0	-	-0.34
2025-04-03	VXRT	0.38	50.0	-	-0.34
2025-04-04	VXRT	0.34	50.0	-	-0.34
2025-04-07	VXRT	0.31	50.0	-	-0.34
2025-04-08	VXRT	0.31	50.0	-	-0.34
2025-04-09	VXRT	0.33	50.0	-	-0.34
2025-04-10	VXRT	0.32	50.0	-	-0.34
2025-04-11	VXRT	0.36	50.0	-	-0.34
2025-04-14	VXRT	0.36	50.0	-	-0.34
2025-04-15	VXRT	0.36	50.0	-	-0.34
2025-04-16	VXRT	0.35	50.0	-	-0.34
2025-04-17	VXRT	0.34	50.0	-	-0.34
2025-04-18	VXRT	0.34	50.0	-	-0.34
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

22 items 1 of 1

22 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-03-20	VXRT	0.00	-7.06	5.90
2025-03-21	VXRT	0.00	-7.06	5.90
2025-03-24	VXRT	0.00	-7.04	5.90
2025-03-25	VXRT	0.00	-7.04	5.90
2025-03-26	VXRT	0.00	-7.04	5.42
2025-03-27	VXRT	0.00	-7.04	5.42
2025-03-28	VXRT	0.00	-7.04	5.42
2025-03-31	VXRT	0.00	-7.04	5.50
2025-04-01	VXRT	0.00	-7.04	5.50
2025-04-02	VXRT	0.00	-7.04	5.50
2025-04-03	VXRT	0.00	-7.04	5.50
2025-04-04	VXRT	0.00	-7.04	5.50
2025-04-07	VXRT	0.00	1.10	5.49
2025-04-08	VXRT	0.00	1.10	5.49
2025-04-09	VXRT	0.00	1.10	5.49
2025-04-10	VXRT	0.00	1.10	5.80
2025-04-11	VXRT	0.00	1.10	5.80
2025-04-14	VXRT	0.00	-15.94	5.80
2025-04-15	VXRT	0.00	-15.94	5.80
2025-04-16	VXRT	0.00	-15.94	5.80
2025-04-17	VXRT	0.00	-15.94	5.80
2025-04-18	VXRT	0.00	-15.94	5.80
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

22 items 1 of 1

Last Quarter Act. EPS

-0.05

Avg. EPS Est. Current Quarter

-0.07

Avg. EPS Est. Next Quarter

-0.08

Insider Transactions

Institutional Transactions

-15.94

Beta

1.33

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

98.6

Max Drawdown 5-Year %

-98.7

Target Price

4.67

P/E

Forward P/E

PEG

P/S

2.73

P/B

1.33

P/Free Cash Flow

EPS

-0.35

Average EPS Est. Cur. Y

-0.34

EPS Next Y. (Est.)

-0.39

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-233.27

Relative Volume

0.45

Return on Equity vs Sector %

-133.6

Return on Equity vs Industry %

-120.2

EPS 1 7Days Diff

0.1

EPS 1 30Days Diff

0.07

EBIT Estimation

Vaxart, Inc. - Common Stock

Sector: Healthcare

Industry: Biotechnology

Employees: 105

Vaxart, Inc., a clinical-stage biotechnology company, discovers and develops oral recombinant protein vaccines based on its vector-adjuvant-antigen standardized technology proprietary oral vaccine platform in the United States. The company's product pipeline includes norovirus vaccine, a bivalent oral tablet vaccine in Phase 2 clinical trial for the GI.1 and GII.4 norovirus strains; coronavirus vaccine, which is in Phase 2 clinical trial, for the treatment of SARS-CoV-2 infection; seasonal influenza vaccine, which is in Phase 2 clinical trial, to treat H1 influenza infection; and human papillomavirus therapeutic vaccine, which is in preclinical stage, that targets HPV-16 and HPV-18 for cervical cancers and precancerous cervical lesions. It has a license agreement with Altesa Biosciences, Inc. to develop and commercialize Vapendavir, a capsid-binding broad-spectrum antiviral. Vaxart, Inc. is headquartered in South San Francisco, California.

stock quote shares VXRT – Vaxart, Inc. Stock Price stock today

news today VXRT – Vaxart, Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch VXRT – Vaxart, Inc. yahoo finance google finance

stock history VXRT – Vaxart, Inc. invest stock market

stock prices VXRT premarket after hours

ticker VXRT fair value insiders trading

Investment involves risk. As a general rule, you should only trade in financial products that you are familiar with and understand the risk associated with them. The risk warning described in each financial product below is not exhaustive, you should carefully consider your investment experience, financial situation, investment objective, risk tolerance level and consult your independent financial adviser as to the suitability of your situation prior making any investment.

VXRT – Vaxart, Inc.

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Relative Volume

Beta

Ticker: VXRT

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Get Started

About

Last Quarter Act. EPS

Average EPS Est. Cur. Y